December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (TSX:BHC)

10.33 +0.41 (+4.13%)
Streaming Delayed Price Updated: 3:08 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Bausch Health Announces Adoption of Shareholder Rights Plan
Via ACCESS Newswire
News headline image
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Via ACCESS Newswire
News headline image
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Via ACCESS Newswire
News headline image
Bausch Health to Announce First Quarter Results on April 30
Via ACCESS Newswire
News headline image
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
Via ACCESS Newswire
News headline image
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
Via ACCESS Newswire
News headline image
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
Via ACCESS Newswire
News headline image
Bausch Health Announces Conditional Redemption of Senior Notes
Via ACCESS Newswire
News headline image
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities
Via ACCESS Newswire
News headline image
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes
Via ACCESS Newswire
News headline image
Bausch Health Announces Third Quarter 2024 Results
Via ACCESSWIRE
News headline image
Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners
Via ACCESSWIRE
News headline image
Bausch Health Announces Second Quarter 2024 Results
Via ACCESSWIRE
News headline image
Bausch Health Responds to Market Rumors
Via ACCESSWIRE
News headline image
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
Via ACCESS Newswire
News headline image
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Via ACCESS Newswire
News headline image
Bausch Health Provides Update on Strategic Alternatives
Via ACCESS Newswire
News headline image
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025
Via ACCESS Newswire
News headline image
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
Via ACCESS Newswire
News headline image
Bausch Health Welcomes Two New Members to the Executive Leadership Team
Via ACCESSWIRE
News headline image
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
Via ACCESSWIRE
News headline image
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day
Via ACCESSWIRE
News headline image
Bausch Health Appoints New Chief Medical Officer and Head of R&D
Via ACCESSWIRE
News headline image
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
Via ACCESSWIRE
News headline image
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Via ACCESSWIRE
News headline image
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Via ACCESSWIRE
News headline image
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
Via ACCESSWIRE
News headline image
Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
Via ACCESSWIRE
News headline image
Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
Via ACCESSWIRE
News headline image
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Via ACCESSWIRE
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.